Dow Up 0.51% Nasdaq Up 0.24%

Trevena, Inc. (TRVN)

-NasdaqGS
5.46 0.23(4.40%) Nov 21, 4:00PM EST
Prev Close:5.23
Open:5.23
Bid:N/A
Ask:23.90 x 4400
1y Target Est:15.33
Beta:N/A
Next Earnings Date:N/A
Day's Range:5.20 - 5.50
52wk Range:4.01 - 9.95
Volume:16,634
Avg Vol (3m):52,423
Market Cap:144.05M
P/E (ttm):N/A
EPS (ttm):-2.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for TRVN

Comparison

Symbol% ChgMkt Cap
TRVNUp 4.40%144.05M
CYTK150.46M
NVS229.73B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.17
Quarterly EPS Est (Dec-14) :-0.56
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Trevena, Inc., a clinical stage biopharmaceutical company, discovers, develops, and intends to commercialize therapeutics for G protein coupled receptors. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback